Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for distal cholangiocarcinoma: An international multicentre retrospective cohort study.

Cholangiocarcinoma Cohort studies Pancreatic neoplasms Pancreaticoduodenectomy Recurrence Survival

Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
22 Apr 2024
Historique:
received: 12 02 2024
revised: 21 03 2024
accepted: 16 04 2024
medline: 4 5 2024
pubmed: 4 5 2024
entrez: 3 5 2024
Statut: aheadofprint

Résumé

Patients undergoing pancreaticoduodenectomy for distal cholangiocarcinoma (dCCA) often develop cancer recurrence. Establishing timing, patterns and risk factors for recurrence may help inform surveillance protocol strategies or select patients who could benefit from additional systemic or locoregional therapies. This multicentre retrospective cohort study aimed to determine timing, patterns, and predictive factors of recurrence following pancreaticoduodenectomy for dCCA. Patients who underwent pancreaticoduodenectomy for dCCA between June 2012 and May 2015 with five years of follow-up were included. The primary outcome was recurrence pattern (none, local-only, distant-only or mixed local/distant). Data were collected on comorbidities, investigations, operation details, complications, histology, adjuvant and palliative therapies, recurrence-free and overall survival. Univariable tests and regression analyses investigated factors associated with recurrence. In the cohort of 198 patients, 129 (65%) developed recurrence: 30 (15%) developed local-only recurrence, 44 (22%) developed distant-only recurrence and 55 (28%) developed mixed pattern recurrence. The most common recurrence sites were local (49%), liver (24%) and lung (11%). 94% of patients who developed recurrence did so within three years of surgery. Predictors of recurrence on univariable analysis were cancer stage, R1 resection, lymph node metastases, perineural invasion, microvascular invasion and lymphatic invasion. Predictors of recurrence on multivariable analysis were female sex, venous resection, advancing histological stage and lymphatic invasion. Two thirds of patients have cancer recurrence following pancreaticoduodenectomy for dCCA, and most recur within three years of surgery. The commonest sites of recurrence are the pancreatic bed, liver and lung. Multiple histological features are associated with recurrence.

Identifiants

pubmed: 38701690
pii: S0748-7983(24)00405-0
doi: 10.1016/j.ejso.2024.108353
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108353

Investigateurs

Matthew Browning (M)
Omar Mownah (O)
Carolina Gonzalez-Abos (C)
Nair Fernandes (N)
Elsa Garcia Moller (EG)
Cristina Dopazo Taboada (CD)
Rupaly Pande (R)
Jameel Alfarah (J)
Samik Bandyopadhyay (S)
Ahmed Abdelrahim (A)
Ayesha Khan (A)
Caitlin Jordan (C)
Jonathan Re Rees (JR)
Joseph Doyle (J)
Harry Blege (H)
William Cambridge (W)
Olga White (O)
Sarah Blacker (S)
Jessie Blackburn (J)
Casie Sweeney (C)
Matyas Fehervari (M)
Madhava Pai (M)
Laith Alghazawi (L)
Anjola Onifade (A)
Daniel Field (D)
Mohammed Gouda (M)
Manuel Maglione (M)
Hytham Ks Hamid (HK)
Julliette Ribaud (J)
Ashitha Nair (A)
Michael Mariathasan (M)
Niamh Grayson (N)
Hassan Ahmed (H)
Catherine Moriarty (C)
Louise White (L)
Mark Priestley (M)
Kerry Bode (K)
Judith Sharp (J)
Rosie Wragg (R)
Beverley Jackson (B)
Samuel Craven (S)
Alan Guerrero (A)
Andre Moguel (A)
Carlos Chan (C)
Michael Jones (M)
Edward Buckley (E)
Nasreen Akter (N)
Kyle Treherne (K)
Gregory Gordon (G)
Daniel Hughes (D)
Tomas Urbonas (T)
Gioia Brachini (G)
Roberto Caronna (R)
Piero Chirletti (P)
Stephanos Pericleous (S)
Krishna Patel (K)
Conrad Shaw (C)
Nolitha Morare (N)
Mohamad K Zaban (MK)
Teresa Perra (T)
Nurul Nadhirah Abd Kahar (NN)
Thomas Hall (T)
Nabeegh Nadeem (N)
Shoura Karar (S)
Ali Arshad (A)
Adam Yarwood (A)
Mohammed Hammoda (M)
Maria Consuelo Artigas (MC)
Sandra Paterna-López (S)

Informations de copyright

© 2024 Published by Elsevier Ltd.

Auteurs

Peter Lz Labib (PL)

University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.

Thomas B Russell (TB)

University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.

Jemimah L Denson (JL)

University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.

Mark A Puckett (MA)

University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.

Fabio Ausania (F)

Hospital Clínic de Barcelona, Barcelona, Spain.

Elizabeth Pando (E)

Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Keith J Roberts (KJ)

University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.

Ambareen Kausar (A)

East Lancashire Hospital NHS Trust, Blackburn, United Kingdom.

Vasileios K Mavroeidis (VK)

University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom; The Royal Marsden NHS Foundation Trust, London, United Kingdom.

Ricky H Bhogal (RH)

The Royal Marsden NHS Foundation Trust, London, United Kingdom.

Gabriele Marangoni (G)

University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom.

Sarah C Thomasset (SC)

NHS Lothian, Edinburgh, United Kingdom.

Adam E Frampton (AE)

Royal Surrey NHS Foundation Trust, Guildford, United Kingdom.

Duncan R Spalding (DR)

Imperial College Healthcare NHS Trust, London, United Kingdom.

Pavlos Lykoudis (P)

Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom.

Ruben Bellotti (R)

Medical University of Innsbruck, Innsbruck, Austria.

Nassir Alhaboob (N)

Ibn Sina Specialist Hospital, Khartoum, Sudan.

Parthi Srinivasan (P)

King's College Hospital NHS Foundation Trust, London, United Kingdom.

Hassaan Bari (H)

Shaukat Khanum Memorial Cancer Hospital, Lahore, Pakistan.

Andrew Smith (A)

Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.

Ismael Dominguez-Rosado (I)

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Daniel Croagh (D)

Monash Medical Centre, Melbourne, Australia.

Rohan G Thakkar (RG)

Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom.

Dhanny Gomez (D)

Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.

Michael A Silva (MA)

Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

Pierfrancesco Lapolla (P)

Policlinico Umberto I Sapienza University of Rome, Rome, Italy.

Andrea Mingoli (A)

Policlinico Umberto I Sapienza University of Rome, Rome, Italy.

Brian R Davidson (BR)

Royal Free London NHS Foundation Trust, London, United Kingdom.

Alberto Porcu (A)

Cliniche San Pietro, Azienda Ospedaliero Universitaria di Sassari, Sassari, Italy.

Nehal S Shah (NS)

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.

Zaed Z Hamady (ZZ)

University Hospital Southampton Foundation Trust, Southampton, United Kingdom.

Bilal A Al-Sarireh (BA)

Swansea Bay University Health Board, Swansea, United Kingdom.

Alejandro Serrablo (A)

Hospital Universitario Miguel Servet, Zaragoza, Spain.

Somaiah Aroori (S)

University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom; University of Plymouth, Plymouth, United Kingdom. Electronic address: s.aroori@nhs.net.

Classifications MeSH